-
Je něco špatně v tomto záznamu ?
Bacterial immunogenic α-galactosylceramide identified in the murine large intestine: dependency on diet and inflammation
J. von Gerichten, D. Lamprecht, L. Opálka, D. Soulard, C. Marsching, R. Pilz, V. Sencio, S. Herzer, B. Galy, V. Nordström, C. Hopf, HJ. Gröne, F. Trottein, R. Sandhoff,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1959 do Před 1 rokem
Freely Accessible Science Journals
od 1959
PubMed Central
od 2008
Europe PubMed Central
od 2008 do Před 1 rokem
Open Access Digital Library
od 1959-10-01
ROAD: Directory of Open Access Scholarly Resources
od 1959
PubMed
31484693
DOI
10.1194/jlr.ra119000236
Knihovny.cz E-zdroje
- MeSH
- Bacteroides fragilis chemie imunologie MeSH
- dieta * MeSH
- galaktosylceramidy genetika imunologie MeSH
- inbrední kmeny myší MeSH
- myši MeSH
- tlusté střevo imunologie metabolismus mikrobiologie MeSH
- zánět imunologie mikrobiologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The glycosphingolipid, α-galactosylceramide (αGalCer), when presented by CD1d on antigen-presenting cells, efficiently activates invariant natural killer T (iNKT) cells. Thereby, it modulates immune responses against tumors, microbial and viral infections, and autoimmune diseases. Recently, the production of αGalCer by Bacteroidetes from the human gut microbiome was elucidated. Using hydrophilic interaction chromatography coupled to MS2, we screened murine intestinal tracts to identify and quantify αGalCers, and we investigated the αGalCer response to different dietary and physiologic conditions. In both the cecum and the colon of mice, we found 1-15 pmol of αGalCer per milligram of protein; in contrast, mice lacking microbiota (germ-free mice) and fed identical diet did not harbor αGalCer. The identified αGalCer contained a β(R)-hydroxylated hexadecanoyl chain N-linked to C18-sphinganine, which differed from what has been reported with Bacteroides fragilis Unlike β-anomeric structures, but similar to αGalCers from B. fragilis, the synthetic form of the murine αGalCer induced iNKT cell activation in vitro. Last, we observed a decrease in αGalCer production in mice exposed to conditions that alter the composition of the gut microbiota, including Western type diet, colitis, and influenza A virus infection. Collectively, this study suggests that αGalCer is produced by commensals in the mouse intestine and reveals that stressful conditions causing dysbiosis alter its synthesis. The consequences of this altered production on iNKT cell-mediated local and systemic immune responses are worthy of future studies.
Department of Cellular and Molecular Pathology German Cancer Research Center Heidelberg Germany
Division of Virus Associated Carcinogenesis German Cancer Research Center Heidelberg Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025544
- 003
- CZ-PrNML
- 005
- 20201222155245.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1194/jlr.RA119000236 $2 doi
- 035 __
- $a (PubMed)31484693
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a von Gerichten, Johanna $u Lipid Pathobiochemistry Group, Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany. Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
- 245 10
- $a Bacterial immunogenic α-galactosylceramide identified in the murine large intestine: dependency on diet and inflammation / $c J. von Gerichten, D. Lamprecht, L. Opálka, D. Soulard, C. Marsching, R. Pilz, V. Sencio, S. Herzer, B. Galy, V. Nordström, C. Hopf, HJ. Gröne, F. Trottein, R. Sandhoff,
- 520 9_
- $a The glycosphingolipid, α-galactosylceramide (αGalCer), when presented by CD1d on antigen-presenting cells, efficiently activates invariant natural killer T (iNKT) cells. Thereby, it modulates immune responses against tumors, microbial and viral infections, and autoimmune diseases. Recently, the production of αGalCer by Bacteroidetes from the human gut microbiome was elucidated. Using hydrophilic interaction chromatography coupled to MS2, we screened murine intestinal tracts to identify and quantify αGalCers, and we investigated the αGalCer response to different dietary and physiologic conditions. In both the cecum and the colon of mice, we found 1-15 pmol of αGalCer per milligram of protein; in contrast, mice lacking microbiota (germ-free mice) and fed identical diet did not harbor αGalCer. The identified αGalCer contained a β(R)-hydroxylated hexadecanoyl chain N-linked to C18-sphinganine, which differed from what has been reported with Bacteroides fragilis Unlike β-anomeric structures, but similar to αGalCers from B. fragilis, the synthetic form of the murine αGalCer induced iNKT cell activation in vitro. Last, we observed a decrease in αGalCer production in mice exposed to conditions that alter the composition of the gut microbiota, including Western type diet, colitis, and influenza A virus infection. Collectively, this study suggests that αGalCer is produced by commensals in the mouse intestine and reveals that stressful conditions causing dysbiosis alter its synthesis. The consequences of this altered production on iNKT cell-mediated local and systemic immune responses are worthy of future studies.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a Bacteroides fragilis $x chemie $x imunologie $7 D001441
- 650 12
- $a dieta $7 D004032
- 650 _2
- $a galaktosylceramidy $x genetika $x imunologie $7 D005699
- 650 _2
- $a zánět $x imunologie $x mikrobiologie $7 D007249
- 650 _2
- $a tlusté střevo $x imunologie $x metabolismus $x mikrobiologie $7 D007420
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a inbrední kmeny myší $7 D008815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Lamprecht, Dominic $u Lipid Pathobiochemistry Group, Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany.
- 700 1_
- $a Opálka, Lukáš $u Lipid Pathobiochemistry Group, Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany. Skin Barrier Research Group, Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
- 700 1_
- $a Soulard, Daphnée $u Centre d'Infection et d'Immunité de Lille, Inserm U1019, CNRS UMR 8204, University of Lille, CHU Lille, Institut Pasteur de Lille, Lille, France.
- 700 1_
- $a Marsching, Christian $u Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany.
- 700 1_
- $a Pilz, Robert $u Lipid Pathobiochemistry Group, Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany. Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
- 700 1_
- $a Sencio, Valentin $u Centre d'Infection et d'Immunité de Lille, Inserm U1019, CNRS UMR 8204, University of Lille, CHU Lille, Institut Pasteur de Lille, Lille, France.
- 700 1_
- $a Herzer, Silke $u Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany.
- 700 1_
- $a Galy, Bruno $u Division of Virus-Associated Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.
- 700 1_
- $a Nordström, Viola $u Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany.
- 700 1_
- $a Hopf, Carsten $u Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany.
- 700 1_
- $a Gröne, Hermann-Josef $u Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany. Institute of Pharmacology, University of Marburg, Marburg, Germany.
- 700 1_
- $a Trottein, François $u Centre d'Infection et d'Immunité de Lille, Inserm U1019, CNRS UMR 8204, University of Lille, CHU Lille, Institut Pasteur de Lille, Lille, France.
- 700 1_
- $a Sandhoff, Roger $u Lipid Pathobiochemistry Group, Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany r.sandhoff@dkfz.de.
- 773 0_
- $w MED00002766 $t Journal of lipid research $x 1539-7262 $g Roč. 60, č. 11 (2019), s. 1892-1904
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31484693 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155241 $b ABA008
- 999 __
- $a ok $b bmc $g 1599689 $s 1116230
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 60 $c 11 $d 1892-1904 $e 20190904 $i 1539-7262 $m Journal of lipid research $n J Lipid Res $x MED00002766
- LZP __
- $a Pubmed-20201125